PETITION

PETITION

Share this post

PETITION
PETITION
💊New Chapter 11 Bankruptcy Filing - Athenex Inc. ($ATNX)💊
Copy link
Facebook
Email
Notes
More

💊New Chapter 11 Bankruptcy Filing - Athenex Inc. ($ATNX)💊

May 17, 2023
∙ Paid

Share this post

PETITION
PETITION
💊New Chapter 11 Bankruptcy Filing - Athenex Inc. ($ATNX)💊
Copy link
Facebook
Email
Notes
More
Share
Athenex

On May 14, 2023, NY-based and publicly-traded Athenex Inc. (“Athenex,” $ATNX) and five affiliates (the “debtors”) filed chapter 11 bankruptcy cases in the Southern District of Texas (Judge Jones).

The debtors are a global oncology-focused biopharma company with one drug in the market (Klisyri); in early ‘21, the debtors had a new drug application Heisman’d by the US Food and Drug Administration, which indicated that the debtors needed to undertake additional clinical trials. New clinical trials require capital and the capital markets have been largely unforgiving of late (in case you were unaware).1 This created a kind of death spiral for Athenex and the debtors have been in a state of triage ever since.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Petition LLC
Publisher Privacy ∙ Publisher Terms
Substack
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More